MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.390
+0.010 (0.72%)
Jul 10, 2026, 4:00 PM EDT - Market closed
MediciNova Employees
MediciNova had 6 employees as of December 31, 2025. The number of employees decreased by 7 or -53.85% compared to the previous year.
Employees
6
Change (1Y)
-7
Growth (1Y)
-53.85%
Revenue / Employee
$99,440
Profits / Employee
-$1,953,349
Market Cap
68.42M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6 | -7 | -53.85% |
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | 0 | - |
| Dec 31, 2022 | 13 | 2 | 18.18% |
| Dec 31, 2021 | 11 | 2 | 22.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 139 |
| MindWalk Holdings | 102 |
| XBiotech | 87 |
| PMV Pharmaceuticals | 54 |
| Pliant Therapeutics | 49 |
| Elicio Therapeutics | 33 |
| iBio, Inc. | 20 |
| ImageneBio | 17 |
MNOV News
- 12 days ago - MediciNova CEO Provides Shareholder Update - GlobeNewsWire
- 4 weeks ago - MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment - GlobeNewsWire
- 6 weeks ago - MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) - GlobeNewsWire
- 6 weeks ago - MediciNova Slides: Corporate presentation - Filings
- 2 months ago - MediciNova Quarterly report: Q1 2026 - Filings
- 2 months ago - MediciNova Proxy statement: Proxy filing - Filings
- 2 months ago - MediciNova Proxy statement: Proxy filing - Filings
- 2 months ago - MediciNova’s peer-reviewed ibudilast study advances clinical translation - TheFly